<DOC>
	<DOCNO>NCT00347958</DOCNO>
	<brief_summary>Objectives : To provide safety data revaccination ADACEL® vaccine . To describe immune response tetanus , diphtheria , pertussis antigen follow revaccination ADACEL® vaccine 4-5 year first vaccination .</brief_summary>
	<brief_title>Descriptive , Open-label , Multicenter Study Safety Redosing With ADACEL® Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Tetany</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Previously receive ADACEL vaccine part Aventis Pasteur study Td501 , Td502 , Td505 . At least 15 great 69 year age time vaccination trial . Signed Institutional Review Board ( IRB ) approve informed assent / consent form . Able attend schedule visit comply trial procedure . For woman , inability become pregnant negative serum/urine pregnancy test . Any condition , opinion investigator , would pose health risk participant interfere evaluation vaccine . Serious chronic disease ( ie , cardiac , renal , neurologic , metabolic , rheumatologic , psychiatric ) unstable might : interfere ability participate fully study ; interfere evaluation vaccine . Known suspected impairment immunologic function . Febrile illness within last 72 hour oral temperature ≥100.4°F ( ≥38°C ) time inclusion . History document tetanus , diphtheria pertussis disease within precede 5 year . Known suspected receipt tetanus , diphtheria pertussiscontaining vaccine since participation Study Td501 , Td502 , Td505 . ( Receipt Menactra vaccine time prior present study permit , subject next exclusion criterion ) . Received vaccine , influenza vaccine , 28day period prior enrollment schedule receive vaccine , influenza vaccine , 28day period enrollment . For influenza vaccine , defer received 14day period prior enrollment schedule receive 14day period enrollment Administration immune globulin blood product within last three month , injected oral corticosteroid immunomodulator therapy within six week study vaccine . Individuals taper dose schedule oral steroid last less 7 day may include trial long receive one course within last two week prior enrollment . Suspected known hypersensitivity vaccine component latex . Unable attend schedule visit comply study procedure . In female childbearing potential , positive equivocal urine pregnancy test enrollment . Nursing mother . Participation another interventional clinical trial 4 week precede enrollment planning participate another interventional clinical trial plan period study . Current abuse alcohol drug addiction may interfere subject 's ability comply trial visit procedure . Thrombocytopenia bleed disorder contraindicate intramuscular ( IM ) vaccination . Subject deprive freedom administrative court order , stress emergency setting , hospitalize without his/her consent .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Tetanus ,</keyword>
	<keyword>Diphtheria ,</keyword>
	<keyword>Pertussis</keyword>
</DOC>